ALOT Form 4: Director Yvonne Schlaeppi receives 3,196 restricted shares

Rhea-AI Filing Summary

Yvonne Schlaeppi, a director of AstroNova, Inc. (ALOT), received a restricted stock award of 3,196 shares on 08/28/2025 under the Amended and Restated Non-Employee Director Annual Compensation Program. The shares were granted at a price of $0 and, after the award, the reporting person beneficially owned 44,426.954 shares. The Form 4 was signed by Daniel Clevenger by power of attorney on 09/02/2025. The filing documents a routine, non-derivative equity grant to a director as part of standard board compensation.

Positive

• Restricted stock award aligns director compensation with shareholder interests

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director equity grant to align interests; no unusual terms disclosed.

The Form 4 shows a standard restricted stock award to a non-employee director under the company's established director compensation program. The grant of 3,196 shares at $0 is reported as a non-derivative acquisition and results in total beneficial ownership of 44,426.954 shares. There is no indication of accompanying unusual vesting, acceleration, or performance-based conditions in the provided text; the filer notes the award arises from the Amended and Restated Non-Employee Director Annual Compensation Program. For governance review, this appears to be a routine compensation action rather than a material corporate event.

Securities Analyst

TL;DR: Small, routine equity issuance; negligible market impact based on disclosed amounts.

The transaction is a non-derivative issuance of 3,196 restricted shares to a director, recorded at $0, increasing the director's beneficial stake to 44,426.954 shares. The filing contains no details on vesting schedule or acceleration rights, and no cash consideration was reported. Given the size of the award in absolute terms and absence of additional transactional detail, this disclosure is unlikely to be material to the company's overall capitalization or near-term financials.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schlaeppi Yvonne

(Last) (First) (Middle)

C/O ASTRONOVA, INC.

600 EAST GREENWICH AVENUE

(Street)

WEST WARWICK RI 02893

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AstroNova, Inc. [ ALOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/28/2025		A(1)		3,196	A	$0	44,426.954	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock award made to the reporting person pursuant to the Amended and Restated Non-Employee Director Annual Compensation Program.

	/s/ Daniel Clevenger, by Power of Attorney	09/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the AstroNova (ALOT) Form 4 report for Yvonne Schlaeppi?

The Form 4 reports a restricted stock award of 3,196 shares to director Yvonne Schlaeppi on 08/28/2025 under the company's director compensation program.

How many shares does Yvonne Schlaeppi beneficially own after the transaction?

Following the reported transaction, the filing shows beneficial ownership of 44,426.954 shares.

What price was reported for the shares in the AstroNova Form 4?

The shares were reported with a transaction price of $0, reflecting a restricted stock award.

Who signed the Form 4 for Yvonne Schlaeppi and when was it signed?

The Form 4 was signed by /s/ Daniel Clevenger, by Power of Attorney on 09/02/2025.

Under what program was the restricted stock award issued?

The filing states the award was made pursuant to the Amended and Restated Non-Employee Director Annual Compensation Program.